← All trials
NCT02565511
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 2, 2015
- Primary completion
- Aug 27, 2023
- Completion date
- Aug 27, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 1340
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- NovartisLead sponsor
- National Institute on Aging (NIA)Collaborator
- AmgenCollaborator
- Alzheimer's AssociationCollaborator
- University of ArizonaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.